Article
Lack of dynamics in the MabA active site kills the enzyme activity: practical consequences for drug-design studies.
Acta crystallographica. Section D, Biological crystallography - 1 Aug 2007
Poncet-Montange Guillaume, Ducasse-Cabanot Stephanie, Quemard Annaick, Labesse Gilles, Cohen-Gonsaud Martin
Abstract excerpt
The MabA protein from Mycobacterium tuberculosis is a validated drug target. Previous structural studies of this protein showed dynamic behaviour in the catalytic site and described motion between an open 'active' holo form (with NADP) and a closed 'inactive' apo form (without NADP). Here, a mutation (G139A) is reported that leads to complete protein inactivation and freezes the catalytic site into its closed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
